FDA
What the FDA has said, listed or proposed: statements, category lists, notices and warning letters.
- FDA
- Advisory committee
- Policy
Where peptide regulation stands right now: a plain-English timeline
A plain-English timeline of peptide regulation as of October 25, 2026: what FDA documents show, what is only reported, and what is still pending.
- Policy
- FDA
This week in peptide policy: October 19–25, 2026
A quiet week for official peptide and compounding actions, October 19-25, 2026, with the reported HHS interim policy still under White House review.
- Telehealth
- Legal
- FDA
Telehealth and compounded drugs: what the FTC and FDA have actually said
What the FTC and FDA have each said about telehealth companies and compounded drugs, from public documents, and what each does not cover.
- Compounding
- FDA
FDA compounding categories explained: what Category 1 and Category 2 mean
What FDA's Category 1 and Category 2 labels for compounded bulk substances mean, and what they do not mean, using FDA's own documents.
